Comparison of Short-Term Clinical and Pathological Outcomes after Transanal versus Laparoscopic Total Mesorectal Excision for Low Anterior Rectal Resection Due to Rectal Cancer: A Systematic Review with Meta-Analysis
- PMID: 30463197
- PMCID: PMC6262322
- DOI: 10.3390/jcm7110448
Comparison of Short-Term Clinical and Pathological Outcomes after Transanal versus Laparoscopic Total Mesorectal Excision for Low Anterior Rectal Resection Due to Rectal Cancer: A Systematic Review with Meta-Analysis
Abstract
Background: Transanal total mesorectal excision (TaTME) is a new technique that is designed to overcome the limits of the open and laparoscopic approach for rectal resections.
Objective: This study is designed to compare TaTME with standard laparoscopic TME (LaTME).
Methods: We searched Medline, Embase, and Scopus databases covering a up to October 2018. Inclusion criteria for study enrolment: (1) study comparing laparoscopic resection of rectal cancer vs. TaTME for rectal malignancy, (2) reporting of overall morbidity, operative time, or major complications.
Results: Eleven non-randomized studies were eligible with a total of 778 patients. We found statistical significant differences in regard to major complications in favour of TaTME (RR = 0.55; 95% CI 0.31⁻0.97; p = 0.04). We did not found significant differences regarding overall complications intraoperative adverse effects, operative time, anastomotic leakage, intra-abdominal abscess occurrence, Surgical Site Infection, reoperations, Length of stay, completeness of mesorectal excision, R0 resection rate, number of harvested lymph nodes, circumferential resection margin, and distal resection margin.
Conclusions: This meta-analysis shows benefits of TaTME technique regarding major postoperative complications. Regarding clinicopathological features transanal approach is not superior to LaTME. Currently, the quality of the evidence on benefits of TaTME is low due to lack of randomized controlled trials, which needs to be taken into consideration in further evaluation of the technique. Further evaluation of TaTME require conducting large randomized control trials.
Keywords: laparoscopic; rectal cancer; total mesorectal excision; transanal.
Conflict of interest statement
The authors declare no conflict of interests.
Figures











Similar articles
-
Transanal versus laparoscopic total mesorectal excision for mid and low rectal cancer: a meta-analysis of short-term outcomes.Wideochir Inne Tech Maloinwazyjne. 2019 Sep;14(3):353-365. doi: 10.5114/wiitm.2019.82798. Epub 2019 Feb 8. Wideochir Inne Tech Maloinwazyjne. 2019. PMID: 31534564 Free PMC article.
-
Total mesorectal excision for low and middle rectal cancer: laparoscopic versus transanal approach-a meta-analysis.Surg Endosc. 2020 Sep;34(9):3908-3919. doi: 10.1007/s00464-019-07160-8. Epub 2019 Oct 15. Surg Endosc. 2020. PMID: 31617090
-
Meta-analysis of transanal total mesorectal excision versus laparoscopic total mesorectal excision in management of rectal cancer.Int J Colorectal Dis. 2020 Apr;35(4):575-593. doi: 10.1007/s00384-020-03545-7. Epub 2020 Mar 2. Int J Colorectal Dis. 2020. PMID: 32124047
-
[Safety and prognosis analysis of transanal total mesorectal excision versus laparoscopic mesorectal excision for mid-low rectal cancer].Zhonghua Wei Chang Wai Ke Za Zhi. 2022 Jun 25;25(6):522-530. doi: 10.3760/cma.j.cn441530-20210811-00321. Zhonghua Wei Chang Wai Ke Za Zhi. 2022. PMID: 35754217 Chinese.
-
Meta-analysis of transanal vs laparoscopic total mesorectal excision of low rectal cancer: Importance of appropriate patient selection.World J Gastrointest Surg. 2022 Dec 27;14(12):1397-1410. doi: 10.4240/wjgs.v14.i12.1397. World J Gastrointest Surg. 2022. PMID: 36632123 Free PMC article.
Cited by
-
Transanal versus laparoscopic total mesorectal excision for mid and low rectal cancer: a meta-analysis of short-term outcomes.Wideochir Inne Tech Maloinwazyjne. 2019 Sep;14(3):353-365. doi: 10.5114/wiitm.2019.82798. Epub 2019 Feb 8. Wideochir Inne Tech Maloinwazyjne. 2019. PMID: 31534564 Free PMC article.
-
Advances in pelvic imaging parameters predicting surgical difficulty in rectal cancer.World J Surg Oncol. 2023 Feb 27;21(1):64. doi: 10.1186/s12957-023-02933-x. World J Surg Oncol. 2023. PMID: 36843078 Free PMC article. Review.
-
Limitations and Concerns with Transanal Total Mesorectal Excision for Rectal Cancer.Clin Colon Rectal Surg. 2022 Feb 28;35(2):141-145. doi: 10.1055/s-0041-1742115. eCollection 2022 Mar. Clin Colon Rectal Surg. 2022. PMID: 35237110 Free PMC article. Review.
-
Clinical Status and Future Prospects of Transanal Total Mesorectal Excision.Front Oncol. 2022 Jan 3;11:752737. doi: 10.3389/fonc.2021.752737. eCollection 2021. Front Oncol. 2022. PMID: 35047386 Free PMC article. Review.
-
Functional outcomes after resections for low rectal tumors: comparison of Transanal with laparoscopic Total Mesorectal excision.BMC Surg. 2019 Jul 5;19(1):79. doi: 10.1186/s12893-019-0550-4. BMC Surg. 2019. PMID: 31277628 Free PMC article.
References
-
- Pędziwiatr M., Małczak P., Mizera M., Witowski J., Torbicz G., Major P., Pisarska M., Wysocki M., Budzyński A. There is no difference in outcome between laparoscopic and open surgery for rectal cancer: A systematic review and meta-analysis on short- and long-term oncologic outcomes. Tech. Coloproctol. 2017;21:595–604. doi: 10.1007/s10151-017-1662-4. - DOI - PMC - PubMed
-
- Havenga K., Enker W.E., Norstein J., Moriya Y., Heald R.J., van Houwelingen H.C., van de Velde C.J. Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer: An international analysis of 1411 patients. Eur. J. Surg. Oncol. 1999;25:368–374. doi: 10.1053/ejso.1999.0659. - DOI - PubMed
LinkOut - more resources
Full Text Sources